Literature DB >> 29633969

Structure of proliferating cell nuclear antigen (PCNA) bound to an APIM peptide reveals the universality of PCNA interaction.

Kodai Hara1, Masayuki Uchida1, Risa Tagata1, Hideshi Yokoyama1, Yoshinobu Ishikawa1, Asami Hishiki1, Hiroshi Hashimoto1.   

Abstract

Proliferating cell nuclear antigen (PCNA) provides a molecular platform for numerous protein-protein interactions in DNA metabolism. A large number of proteins associated with PCNA have a well characterized sequence termed the PCNA-interacting protein box motif (PIPM). Another PCNA-interacting sequence termed the AlkB homologue 2 PCNA-interacting motif (APIM), comprising the five consensus residues (K/R)-(F/Y/W)-(L/I/V/A)-(L/I/V/A)-(K/R), has also been identified in various proteins. In contrast to that with PIPM, the PCNA-APIM interaction is less well understood. Here, the crystal structure of PCNA bound to a peptide carrying an APIM consensus sequence, RFLVK, was determined and structure-based interaction analysis was performed. The APIM peptide binds to the PIPM-binding pocket on PCNA in a similar way to PIPM. The phenylalanine and leucine residues within the APIM consensus sequence and a hydrophobic residue that precedes the APIM consensus sequence are crucially involved in interactions with the hydrophobic pocket of PCNA. This interaction is essential for overall binding. These results provide a structural basis for regulation of the PCNA interaction and might aid in the development of specific inhibitors of this interaction.

Entities:  

Keywords:  APIM; PCNA; PIPM; proliferating cell nuclear antigen; protein–protein interactions

Mesh:

Substances:

Year:  2018        PMID: 29633969      PMCID: PMC5893992          DOI: 10.1107/S2053230X18003242

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  24 in total

1.  Structural basis for recruitment of human flap endonuclease 1 to PCNA.

Authors:  Shigeru Sakurai; Ken Kitano; Hiroto Yamaguchi; Keisuke Hamada; Kengo Okada; Kotaro Fukuda; Makiyo Uchida; Eiko Ohtsuka; Hiroshi Morioka; Toshio Hakoshima
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

2.  XDS.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

3.  Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication.

Authors:  Chandanamali Punchihewa; Akira Inoue; Asami Hishiki; Yoshihiro Fujikawa; Michele Connelly; Benjamin Evison; Youming Shao; Richard Heath; Isao Kuraoka; Patrick Rodrigues; Hiroshi Hashimoto; Masanobu Kawanishi; Mamoru Sato; Takashi Yagi; Naoaki Fujii
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

4.  Polyubiquitinated PCNA recruits the ZRANB3 translocase to maintain genomic integrity after replication stress.

Authors:  Alberto Ciccia; Amitabh V Nimonkar; Yiduo Hu; Ildiko Hajdu; Yathish Jagadheesh Achar; Lior Izhar; Sarah A Petit; Britt Adamson; John C Yoon; Stephen C Kowalczykowski; David M Livingston; Lajos Haracska; Stephen J Elledge
Journal:  Mol Cell       Date:  2012-06-14       Impact factor: 17.970

5.  Crystal structure of human PCNA in complex with the PIP box of DVC1.

Authors:  Yong Wang; Min Xu; Tao Jiang
Journal:  Biochem Biophys Res Commun       Date:  2016-04-13       Impact factor: 3.575

6.  Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design.

Authors:  George Kontopidis; Su-Ying Wu; Daniella I Zheleva; Paul Taylor; Campbell McInnes; David P Lane; Peter M Fischer; Malcolm D Walkinshaw
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-28       Impact factor: 11.205

Review 7.  PCNA binding through a conserved motif.

Authors:  E Warbrick
Journal:  Bioessays       Date:  1998-03       Impact factor: 4.345

8.  The transcription factor TFII-I promotes DNA translesion synthesis and genomic stability.

Authors:  Farjana J Fattah; Kodai Hara; Kazi R Fattah; Chenyi Yang; Nan Wu; Ross Warrington; David J Chen; Pengbo Zhou; David A Boothman; Hongtao Yu
Journal:  PLoS Genet       Date:  2014-06-12       Impact factor: 5.917

9.  Structural insights into the function of ZRANB3 in replication stress response.

Authors:  Marek Sebesta; Christopher D O Cooper; Antonio Ariza; Christopher J Carnie; Dragana Ahel
Journal:  Nat Commun       Date:  2017-06-16       Impact factor: 14.919

10.  Identification of a novel, widespread, and functionally important PCNA-binding motif.

Authors:  Karin M Gilljam; Emadoldin Feyzi; Per A Aas; Mirta M L Sousa; Rebekka Müller; Cathrine B Vågbø; Tara C Catterall; Nina B Liabakk; Geir Slupphaug; Finn Drabløs; Hans E Krokan; Marit Otterlei
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

View more
  4 in total

1.  The p12 subunit of human polymerase δ uses an atypical PIP box for molecular recognition of proliferating cell nuclear antigen (PCNA).

Authors:  Amaia Gonzalez-Magaña; Alain Ibáñez de Opakua; Miguel Romano-Moreno; Javier Murciano-Calles; Nekane Merino; Irene Luque; Adriana L Rojas; Silvia Onesti; Francisco J Blanco; Alfredo De Biasio
Journal:  J Biol Chem       Date:  2019-01-17       Impact factor: 5.157

Review 2.  Post-Translational Modifications of PCNA: Guiding for the Best DNA Damage Tolerance Choice.

Authors:  Gemma Bellí; Neus Colomina; Laia Castells-Roca; Neus P Lorite
Journal:  J Fungi (Basel)       Date:  2022-06-10

3.  ELM-the eukaryotic linear motif resource in 2020.

Authors:  Manjeet Kumar; Marc Gouw; Sushama Michael; Hugo Sámano-Sánchez; Rita Pancsa; Juliana Glavina; Athina Diakogianni; Jesús Alvarado Valverde; Dayana Bukirova; Jelena Čalyševa; Nicolas Palopoli; Norman E Davey; Lucía B Chemes; Toby J Gibson
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

Review 4.  Human PCNA Structure, Function and Interactions.

Authors:  Amaia González-Magaña; Francisco J Blanco
Journal:  Biomolecules       Date:  2020-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.